Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 28,775 |
|
|||||
| News | - | ||||||
| Day High | 2.29 | Low High |
|||||
| Day Low | 2.05 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| BriaCell Therapeutics Corporation | BCTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0924 | -4.30% | 2.0552 | 15:50:15 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.16 | 2.05 | 2.29 | 2.1476 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 199 | 28,775 | $ 2.16 | $ 62,201 | - | 2.01 - 7.59 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:50:15 | 104 | $ 2.0552 | USD |
BriaCell Therapeutics Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 169.41M | 15.98M | - | 0 | -20.3M | -1.27 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BriaCell Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BCTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.71 | 2.8499 | 2.01 | 2.35 | 64,489 | -0.6548 | -24.16% |
| 1 Month | 2.35 | 3.03 | 2.01 | 2.65 | 75,097 | -0.2948 | -12.54% |
| 3 Months | 3.96 | 4.37 | 2.01 | 3.10 | 87,030 | -1.90 | -48.10% |
| 6 Months | 5.56 | 5.97 | 2.01 | 3.98 | 100,401 | -3.50 | -63.04% |
| 1 Year | 7.33 | 7.59 | 2.01 | 5.20 | 98,836 | -5.27 | -71.96% |
| 3 Years | 3.27 | 12.47 | 2.01 | 6.81 | 874,913 | -1.21 | -37.15% |
| 5 Years | 4.24 | 12.47 | 2.01 | 6.60 | 900,900 | -2.18 | -51.53% |
BriaCell Therapeutics Description
| BriaCell Therapeutics Corp is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell, in collaboration with Incyte Corp., is conducting a Phase I/IIa clinical trial of Bria-IMT, its lead candidate, in a Combination Study with Incyte drugs, INCMGA00012, and epacadostat, in advanced breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing and is designed to produce a potent and selective immune response against the cancer of each patient eliminating the time, expense and complex manufacturing logistics associated with immunotherapies. |
